Remove Networking Remove Pharmaceutical research Remove Prospecting Remove Safety
article thumbnail

The Traditional Pharma Model Isn’t Working – It’s Time to Evolve!

PharmaKinnex

More convenience and safety? But what happens when that in-person meeting is no longer a viable option for your prospect? Bearing the brunt of these COVID19 restrictions, pharmaceutical reps have had a hard time getting in the door to make sales, and their employers have noticed: Limited In-Person Access To HCPs.

Pharma 52
article thumbnail

Dawn of a new indication: how to study drugs for aging 

Pharmaceutical Technology

Based on preclinical research for their impact on aging, well-known drugs like metformin and rapamycin are already being considered for off-label usage, due to their accepted safety profile and cost-effectiveness. GlobalData’s expansive report examines the business environment and trends that shape the Biopharmaceutical industry.

FDA 145